Piperazine derivatives and their use as therapeutic agents

Details for Australian Patent Application No. 2004261268 (hide)

Owner Xenon Pharmaceuticals Inc.

Inventors Li, Wenbao; Sun, Shaoyi; Kodumuru, Vishnumurthy; Winther, Michael D.; Kamboj, Rajender; Holladay, Mark W.; Liu, Shifeng; Abreo, Melwyn; Sviridov, Serguei; Gschwend, Heinz W.; Tu, Chi

Agent Davies Collison Cave

Pub. Number AU-B-2004261268

PCT Pub. Number WO2005/011657

Priority 60/491,095 30.07.03 US

Filing date 29 July 2004

Wipo publication date 10 February 2005

Acceptance publication date 12 March 2009

International Classifications

A61K 31/00 (2006.01)

A61K 31/497 (2006.01)

A61K 31/501 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

C07D 237/20 (2006.01) Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings

C07D 237/22 (2006.01) Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings

C07D 239/42 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 241/26 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 403/08 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/08 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/08 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/011657 Priority application(s): WO2005/011657

12 March 2009 Application Accepted

  Published as AU-B-2004261268

9 July 2009 Standard Patent Sealed

24 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004261277-Permeation-Resistant osmotic engine and dosage form for controlled release of a liquid active agent formulation

2004261267-Pyridyl derivatives and their use as therapeutic agents